GSK Avandamet Cost-Effectiveness For Pediatric Use Will Be Studied By NIH
This article was originally published in The Pink Sheet Daily
Executive Summary
The study will randomize 750 children aged 10-17 to a regimen of Avandamet, metformin or metformin plus lifestyle change.